Skip to content

Clinical trials

Completed Cardiomyopathies trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Status: Completed Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20071
20111
20121
20145
20192
20203
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals4
Ionis Pharmaceuticals, Inc.2
Bayer1
Celladon Corporation1
Eidos Therapeutics, a BridgeBio company1
Imperial College London1
Intellia Therapeutics1
King's College London1
LivaNova1
Mallinckrodt1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies19
Heart Failure8
Amyloidosis5
Alzheimer Disease4
Amyloid Neuropathies, Familial3
Heart Diseases3
Cardiotoxicity2
Fibrosis2
Acute Lung Injury1
Adenoviridae Infections1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.